NO2672950T3 - - Google Patents

Info

Publication number
NO2672950T3
NO2672950T3 NO12716475A NO12716475A NO2672950T3 NO 2672950 T3 NO2672950 T3 NO 2672950T3 NO 12716475 A NO12716475 A NO 12716475A NO 12716475 A NO12716475 A NO 12716475A NO 2672950 T3 NO2672950 T3 NO 2672950T3
Authority
NO
Norway
Application number
NO12716475A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43629806&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2672950(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NO2672950T3 publication Critical patent/NO2672950T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Polymers & Plastics (AREA)
NO12716475A 2011-02-11 2012-02-10 NO2672950T3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20115135A FI126259B (fi) 2011-02-11 2011-02-11 Mikrofibrilloitu selluloosa käytettäväksi erityisesti atooppisen ihotulehduksen ja psoriasiksen hoidossa
PCT/FI2012/050129 WO2012107648A1 (fr) 2011-02-11 2012-02-10 Effet anti-inflammatoire des microfibrilles de cellulose

Publications (1)

Publication Number Publication Date
NO2672950T3 true NO2672950T3 (fr) 2018-05-12

Family

ID=43629806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12716475A NO2672950T3 (fr) 2011-02-11 2012-02-10

Country Status (8)

Country Link
US (1) US9018189B2 (fr)
EP (1) EP2672950B1 (fr)
JP (1) JP6386226B2 (fr)
DK (1) DK2672950T3 (fr)
ES (1) ES2661582T3 (fr)
FI (1) FI126259B (fr)
NO (1) NO2672950T3 (fr)
WO (1) WO2012107648A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI126513B (fi) * 2011-01-20 2017-01-13 Upm Kymmene Corp Menetelmä lujuuden ja retention parantamiseksi ja paperituote
US20140134217A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Leave-on compositions containing cellulose materials
US9370478B2 (en) 2012-11-09 2016-06-21 Johnson & Johnson Consumer Inc. Skin care compositions containing cotton and citrus-derived materials
US20140134218A1 (en) 2012-11-09 2014-05-15 Johnson & Johnson Consumer Companies, Inc. Rinse-off skin care compositions containing cellulosic materials
FI126109B (en) 2013-02-22 2016-06-30 Upm Kymmene Corp Nanofibril polysaccharide for use in the control and prevention of constriction and scarring
FR3016296B1 (fr) * 2014-01-14 2021-06-25 Feeligreen Dispositif pour l'electrostimulation et/ou l'iontophorese
FI129421B (fi) * 2014-03-12 2022-02-15 Maelkki Yrjoe Nanoselluloosan ja sen esiasteiden valmistus ja käyttö
FI125758B (en) 2014-12-22 2016-02-15 Upm Kymmene Corp A method for reducing the viscosity of nanofibrillar cellulose hydrogel
FI129934B (en) 2015-02-13 2022-11-15 Upm Kymmene Corp Sewing thread, method of making sewing thread and its use
EP3228329B1 (fr) * 2016-04-06 2022-06-08 UPM-Kymmene Corporation Procédé de préparation de produit médical comprenant de la cellulose nanofibrillaire et un tel produit
EP3519549A4 (fr) 2016-09-30 2020-06-03 Novaflux, Inc. Compositions de nettoyage et de décontamination
CA3095752A1 (fr) 2018-04-03 2019-10-10 Novaflux, Inc. Composition de nettoyage ayant un polymere superabsorbant
WO2020031186A1 (fr) * 2018-08-06 2020-02-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Formulations topiques à base de cellulose
US11918677B2 (en) 2019-10-03 2024-03-05 Protegera, Inc. Oral cavity cleaning composition method and apparatus
US12064495B2 (en) 2019-10-03 2024-08-20 Protegera, Inc. Oral cavity cleaning composition, method, and apparatus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4378381A (en) 1980-10-31 1983-03-29 International Telephone And Telegraph Corporation Suspensions containing microfibrillated cellulose
JPS6239507A (ja) * 1985-08-13 1987-02-20 Daicel Chem Ind Ltd 皮膚手入れ用化粧料
DE4328871A1 (de) 1993-08-27 1995-03-02 Beiersdorf Ag Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis
FR2730252B1 (fr) 1995-02-08 1997-04-18 Generale Sucriere Sa Cellulose microfibrillee et son procede d'obtention a partir de pulpe de vegetaux a parois primaires, notamment a partir de pulpe de betteraves sucrieres.
FR2744632B1 (fr) 1996-02-13 1998-03-27 Oreal Utilisation d'une suspension aqueuse de microfibrilles d'origine naturelle pour la preparation de compositions cosmetiques ou dermatologiques, compositions cosmetiques ou dermatologiques et applications
JPH09275424A (ja) 1996-04-04 1997-10-21 Matsushita Electric Ind Co Ltd 送信装置
BR9710328A (pt) * 1996-07-15 1999-08-17 Rhodia Chimie Sa Composi-Æo processo de prepara-Æo da mesma suspensÆo e utiliza-Æo de celulose carboxilada da composi-Æo e da suspensÆo
FR2769836B1 (fr) * 1997-10-21 2000-03-10 Rhodia Chimie Sa Utilisation de nanofibrilles de cellulose essentiellement amorphes associees a au moins un compose organique polyhydroxyle dans des formulations cosmetiques
FR2822679A1 (fr) 2001-03-30 2002-10-04 Oreal Composition cosmetique comprenant un melange de fibres
JP4961772B2 (ja) * 2005-03-01 2012-06-27 Ｊｎｃ株式会社 硫酸化セルロース及びその塩から選ばれた化合物並びに皮膚炎治療剤
US8951551B2 (en) * 2005-08-31 2015-02-10 Board Of Regents, The University Of Texas System Multiribbon nanocellulose as a matrix for wound healing
US20100254961A1 (en) 2007-09-05 2010-10-07 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
AU2008324033B2 (en) * 2007-11-05 2014-01-09 Humanitarian Scientific Llc Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias

Also Published As

Publication number Publication date
EP2672950B1 (fr) 2017-12-13
US9018189B2 (en) 2015-04-28
JP2014505093A (ja) 2014-02-27
EP2672950A1 (fr) 2013-12-18
US20140045785A1 (en) 2014-02-13
JP6386226B2 (ja) 2018-09-05
FI20115135A0 (fi) 2011-02-11
ES2661582T3 (es) 2018-04-02
DK2672950T3 (en) 2018-02-12
WO2012107648A1 (fr) 2012-08-16
FI20115135L (fi) 2012-08-12
FI126259B (fi) 2016-09-15
FI20115135A (fi) 2012-08-12

Similar Documents

Publication Publication Date Title
BR112013022641A2 (fr)
AP3853A (fr)
BR112013031251A2 (fr)
BR112013027245A2 (fr)
BR112013024383A2 (fr)
BR112013026905A2 (fr)
BR112013023185A2 (fr)
BR112013022995A2 (fr)
BR112013027830A2 (fr)
BR112013026744A2 (fr)
BR112013017670A2 (fr)
BR112013023927A2 (fr)
BR112013024365A2 (fr)
BR112013028733A2 (fr)
BR112013027121A2 (fr)
BR112013027452A2 (fr)
AP2016009466A0 (fr)
BR112013031556A2 (fr)
BR112013024588A2 (fr)
BR112013026790A2 (fr)
BR112013032377A2 (fr)
BR112013032380A2 (fr)
BR112013032366A2 (fr)
BR112013026895A2 (fr)
BR112013018949A2 (fr)